RecruitingNot Applicable

Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia

United States218 participantsStarted 2024-12-03

Plain-language summary

The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant patients with Pre-gestational (Type 1 or Type 2) or Gestational Diabetes * Singleton Gestations * Greater than or equal to 35 weeks gestation * Planned for vaginal delivery at the University of Pittsburgh Medical Center Magee-Womens Hospital (UPMC MWH) Exclusion Criteria: * Major fetal anomalies anticipated to require NICU admission * Planned Cesarean delivery

What they're measuring

Immediate postnatal Neonatal hypoglycemia

Timeframe: Within the first 24 hours after delivery.

Trial details

NCT IDNCT06643351

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05

Contact for this trial

Praveen Ramesh, M.D.

412-641-4455 rameshp2@upmc.edu

View on ClinicalTrials.gov More Gestational Diabetes Mellitus in Pregnancy trials